Copyright © 2021. Inderes Oyj. All rights reserved.

Remedy’s Q3 figures were clearly below our expectations. This was mainly due to timing factors and a reminder of the major fluctuations in the company's business between quarters. In operational terms, Remedy's strategy and game projects have progressed as planned, and the company reiterated with confidence its outlook that anticipates earnings growth for the whole year. Thus, the big picture of the company's growth story remains unchanged and there are clear drivers behind the significant earnings growth expectations that have been built for Q4. In our estimate, Remedy's game projects that are under development will enable the company to take the next significant growth leap in 2023-2024. When looking at these years, we consider the share valuation attractive.

Show your love by gifting this content to a fellow investor. As a Premium subscriber you can gift Premium-content to a free-user friend. Gift link:

Trade. (Remedy)

Remedy Entertainment Plc is a globally successful game company founded in 1995 and based in Espoo, Finland. We create story-driven console and computer games with renowned partners such as 505 Games, Microsoft, Rockstar Games and Smilegate. Remedy has two games under development, CrossFire 2 and Project 7, built using our proprietary Northlight game engine and tools. Our past games include Death Rally, Max Payne, Max Payne 2: The Fall of Max Payne, Alan Wake, Alan Wake’s American Nightmare and Quantum Break.